West Pharmaceutical Services Executive Compensation
West Pharmaceutical Services is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
West Pharmaceutical Services discloses FY2025 compensation for 8 named executive officers, totaling $29.1M. Robert W. McMahon, the Executive Officer, accounts for 41% of that combined total.
Cash compensation (salary plus bonus) made up 26% of West Pharmaceutical Services's FY2025 tracked executive pay, with stock awards accounting for 58%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, West Pharmaceutical Services's combined tracked executive pay of $29.1M ranks in the 81th percentile (industry median: $12.5M). Its highest-paid executive, Robert W. McMahon, ranks in the 65th percentile for top-executive pay in the sector (industry median: $6.0M).